MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
155.47
-1.26
-0.80%
After Hours: 155.60 +0.13 +0.08% 19:57 11/08 EST
OPEN
157.00
PREV CLOSE
156.73
HIGH
157.08
LOW
155.41
VOLUME
8.93M
TURNOVER
--
52 WEEK HIGH
168.85
52 WEEK LOW
140.91
MARKET CAP
374.31B
P/E (TTM)
25.70
1D
5D
1M
3M
1Y
5Y
1D
Notable Two Hundred Day Moving Average Cross - JNJ
NASDAQ · 10h ago
J&J seeks approval of Darzalex for early-stage multiple myeloma
Seeking Alpha · 11h ago
Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment
NASDAQ · 12h ago
Johnson & Johnson submits applications for new indications for Darzalex
TipRanks · 14h ago
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
NASDAQ · 17h ago
Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?
Barchart · 19h ago
What's Next For Merck Stock After An Upbeat Q3?
NASDAQ · 1d ago
Should You Pick Bristol Myers Squibb Stock At $55?
NASDAQ · 1d ago
More
About JNJ
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.